Unusual 11 Mid-Day Movers 8/24: (NYMX) (URRE) (BREW) Higher; (EXPR) (BSPM) (LZB) Lower

August 24, 2016 12:51 PM EDT

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Nymox Pharmaceutical Corporation (Nasdaq: NYMX) 28.8% HIGHER; announces successful new study results from the long-term blinded placebo crossover group from the U.S. Phase 3 trials for fexapotide, the Company's lead compound in late stage development for enlarged prostate (BPH) and for localized prostate cancer.

Uranium Resources, Inc. (URI) (Nasdaq: URRE) 28.8% HIGHER; announced that it has staked approximately 4,600 acres (1,860 hectares) of placer mining claims covering a prospective target for lithium-enriched brines in the Columbus Salt Marsh area of west-central Nevada. The target area, known as the Nina Project, is situated within a region of known lithium mineralization and is approximately 27 miles (43 kilometers) northwest of the Clayton Valley/Silver Peak lithium brine mine of Albemarle Corporation, the only operating lithium brine recovery operation in the United States.

Express (NYSE: EXPR) 25.0% LOWER; reported Q2 EPS of $0.13, $0.04 worse than the analyst estimate of $0.17. Revenue for the quarter came in at $504.8 million versus the consensus estimate of $520.95 million. Comparable sales (including e-commerce sales) decreased 8%, compared to a 7% increase in the second quarter of 2015. (The Street was looking for a drop of 4.7 percent.) Express sees FY2016 EPS of $1.00-$1.14, versus the consensus of $1.46.

Craft Brew Alliance, Inc. (CBA) (Nasdaq: BREW) 22.7% HIGHER; Craft Brew Alliance and Anheuser-Busch (AB) announced today a series of new commercial agreements that expand and strengthen the companies’ long-term relationship and create new growth opportunities for both companies. The agreements include an amended and extended master distribution agreement, a new contract brewing arrangement, and a new international distribution agreement.

Aehr Test Systems (Nasdaq: AEHR) 17.0% HIGHER; Aehr Test Systems and Semics Inc. announced a development and manufacturing partnership between the two companies, including an investment by Semics in 200,000 shares of Aehr Test Systems common stock.

Pharmerica (NYSE: PMC) 15.0% HIGHER; said working with banks to explore a potential sale, according to Reuters.

TG Therapeutics, Inc. (Nasdaq: TGTX) 14.8% HIGHER; announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation for the Company’s oral, next generation PI3K Delta inhibitor, TGR-1202, for the treatment of patients with chronic lymphocytic leukemia (CLL). TGR-1202 is currently being evaluated in the UNITY-CLL Phase 3 Trial for patients with both frontline and previously treated CLL.

Biostar Pharma (Nasdaq: BSPM) 13.1% LOWER; continuing lower from Q2 results on Monday.

La-Z-Boy (NYSE: LZB) 13.3% LOWER; reported Q1 EPS of $0.28, $0.01 worse than the analyst estimate of $0.29. Revenue for the quarter came in at $340.8 million versus the consensus estimate of $358.79 million. Same-store sales for the La-Z-Boy Furniture Galleries® network declined 1.9% versus an increase of 5.3% in last year's first quarter.

Lombard Medical (Nasdaq: EVAR) 12.8% LOWER; reported Q2 EPS of ($0.42), $0.02 worse than the analyst estimate of ($0.40). Revenue for the quarter came in at $3.8 million versus the consensus estimate of $3.8 million. Sees FY16 revenue of $13 - $15 million, versus the consensus at $17.6 million.

Lantronix (Nasdaq: LTRX) 10.0% LOWER; reported Q4 EPS of $0.01, $0.06 better than the analyst estimate of ($0.05). Revenue for the quarter came in at $10.5 million versus the consensus estimate of $9.3 million.

To get this report daily visit http://www.streetinsider.com/entities/Unusual+11+Mid-Day+Movers.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Special Reports

Related Entities

Unusual 11 Mid-Day Movers

Add Your Comment